Results 21 to 30 of about 19,123 (197)

Refractory tertiary hyperparathyroidism after calcimimetics and delayed parathyroidectomy in a kidney transplant recipient

open access: yesKidney Research and Clinical Practice, 2012
Persistent hyperparathyroidism affects renal outcomes and mortality. After kidney transplantation, cinacalcet is not approved as treatment for hyperparathyroidism. Parathyroidectomy, on the other hand, reverses electrolytes and mineral bone metabolism in
Ekamol Tantisattamo, David D. Ono
doaj   +1 more source

Endoscopic parathyroidectomy

open access: yesBiomedicine & Pharmacotherapy, 2000
During the last three years, minimally invasive procedures have been adopted for the surgical treatment of primary hyperparathyroidism, because preoperative localization studies such as a high-resolution ultrasonography and sestamibi scintigraphy.
Y, Ikeda, H, Takami
openaire   +2 more sources

Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease [PDF]

open access: yes, 1972
In eight patients with advanced renal insufficiency (inulin clearance 1.4-9.1 ml/min), concentrations of serum calcium (S[Ca]) and phosphorus (S[P]) were maintained normal (S[Ca] > 9.0 mg/100 ml, (S[P] < 3.5 mg/100 ml) for at least 20 consecutive days ...
Halgrimson, CG   +5 more
core   +1 more source

Lack of evidence does not justify neglect. how can we address unmet medical needs in calciphylaxis [PDF]

open access: yes, 2016
Calcific uraemic arteriolopathy (CUA), or calciphylaxis, is a rare disease predominantly occurring in comorbidity with dialysis. Due to the very low frequency of CUA, prospective studies on its management are lacking and even anecdotal reports on ...
Brandenburg, Vincent Matthias   +14 more
core   +1 more source

Eucalcemic Parathyroid Hormone Elevation After Parathyroidectomy for Primary Sporadic Hyperparathyroidism: Risk Factors, Trend, and Outcome [PDF]

open access: yes, 2011
BACKGROUND: Patients with eucalcemic parathyroid hormone elevation (ePTH) after parathyroidectomy for primary hyperparathyroidism (HPT) may be at risk of recurrence.
Brian Hung-Hin Lang   +3 more
core   +2 more sources

Imaging and choosing the right patients for transoral endoscopic parathyroidectomy vestibular approach

open access: yesWorld Journal of Otorhinolaryngology-Head and Neck Surgery, 2020
Advances in imaging for preoperative localization have propelled the widespread adoption of minimally invasive/focused parathyroidectomy in primary hyperparathyroidism.
Rohit Ranganath   +5 more
doaj   +1 more source

Evaluation of a Phosphate Management Protocol to Achieve Optimum Serum Phosphate Levels in Hemodialysis Patients [PDF]

open access: yes, 2008
Original article can be found at: http://www.sciencedirect.com/science/journal/10512276 Copyright National Kidney Foundation, Inc. DOI: 10.1053/j.jrn.2008.05.003To evaluate the effectiveness of a protocol designed to optimize serum phosphate levels in ...
Cheung, C.F.   +5 more
core   +1 more source

A comparison of surgical treatments for tertiary hyperparathyroidism. A systematic review [PDF]

open access: yesFolia Medica
Introduction: Tertiary hyperparathyroidism develops in patients who have secondary hyperparathyroidism that persists despite successful kidney transplantation or in patients who are on chronic dialysis.
Panagoula Oikonomou   +5 more
doaj   +3 more sources

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study [PDF]

open access: yesKidney Research and Clinical Practice, 2022
Background Hyperparathyroidism is common in patients with chronic kidney disease with reduced renal function and has been observed after kidney transplantation.
Suyun Jung   +10 more
doaj   +1 more source

Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial [PDF]

open access: yes, 2007
Background Secondary hyperparathyroidism (sHPT) is common in patients with chronic renal failure. Despite the initiation of new therapeutic agents, several patients will require parathyroidectomy (PTX).
Katja Schlosser   +73 more
core   +2 more sources

Home - About - Disclaimer - Privacy